Discovery of Biaryl Anthranilides as Full Agonists for the High Affinity Niacin Receptor

Discovery of Biaryl Anthranilides as Full Agonists for the High Affinity Niacin Receptor Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate Tetrahydro anthranilic acid as a surrogate for anthranilic acid: Application to the discovery of potent niacin receptor agonists Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a) Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A Analogues of Acifran:  Agonists of the High and Low Affinity Niacin Receptors, GPR109a and GPR109b Nicotinic Acid Receptor Agonists